Kiniksa Pharmaceuticals
KNSA
#4658
Rank
โ‚ฌ1.36 B
Marketcap
๐Ÿ‡ง๐Ÿ‡ฒ
Country
18,73ย โ‚ฌ
Share price
3.70%
Change (1 day)
12.23%
Change (1 year)

EPS for Kiniksa Pharmaceuticals (KNSA)

EPS in 2023 (TTM): -0,10ย โ‚ฌ

According to Kiniksa Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -0,09666ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of 2,32ย โ‚ฌ an increase over its 2021 EPS that were of -2,02ย โ‚ฌ.

EPS history for Kiniksa Pharmaceuticals from 2017 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-0,10ย โ‚ฌ-104.52%
20222,32ย โ‚ฌ-214.78%
2021-2,02ย โ‚ฌ-10.85%
2020-2,27ย โ‚ฌ-14.57%
2019-2,65ย โ‚ฌ6.33%
2018-2,50ย โ‚ฌ42.15%
2017-1,76ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-1,92ย โ‚ฌ 1,881.82%๐Ÿ‡บ๐Ÿ‡ธ USA